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During the first year of my PhD programme I took part in a project dealing 
with the identification of XCD44 gene expression pattern and its functional role 
during Xenopus laevis muscle development. These results are reported in the 
last part of this thesis as publications in “Development” journal (Ori, Nardini, 
Casini et al., 2006). 
 
 
This PhD thesis describes all the work I have done in the last two years. In 
this period my efforts were focused on the project “Hyaluronan role in Xenopus 
laevis visceral skeleton morphogenesis” that is the subject of this manuscript. 
Moreover, as complementary studies, I report in the thesis the expression patter 
of the Xversican and XRHAMM genes during Xenopus laevis development. The 
Xversican cDNA has been cloned in collaboration with the group of Prof. 
Calatroni, University of Messina and the data regarding the identification and the 
gene expression of this gene are reported in the manuscript attached at the end 
of this thesis (Casini et al., 2008) actually submitted to an international peer 
review journal (“International Journal Developmental Biology”). 








Hyaluronan is a crucial glycosaminoglycan of vertebrate extracellular 
matrix. In dynamic cellular systems, such as embryonic development, 
tissue regeneration and tumorigenesis, hyaluronan has been shown to 
influence cell behaviour, including cell migration, proliferation and 
differentiation both by assembling the interstitial matrices and by directly 
influencing cell behaviour via interaction with signal transducing receptors 
such as CD44. 
We are using Xenopus laevis to study the role of hyaluronan and CD44 
in vivo during cell migration and differentiation processes. The spatio-
temporal gene expression profile of the three known vertebrate hyaluronan 
synthases (Has1, Has2 and Has3) shows a very close conservation of 
Xenopus laevis Has genes with that of mammals. Recently, we 
demonstrated a critical role of XHas2 and XCD44 during muscle formation 
and precursor muscle cell migration. To further dissect the role of these 
molecules on migration and differentiation processes, during my PhD 
programme I then focused my attention on cranial neural crest cells (NCCs) 
development, knocking-down the XHas1, XHas2 and XCD44 gene 
functions. I showed that the hyaluronan synthases and the hyaluronan 
receptor present a dynamic expression pattern during cranial NCCs 
development suggesting multiple roles in the various steps of cranial NCCs 
migration and differentiation. I demonstrated that XHas1 and XHas2, in 
concert with XCD44, are involved in the NCCs migration and that 
hyaluronan, but not XCD44, is required in post-migratory stages to support 
cells survival. In order to investigate possible action mechanisms 
underlying hyaluronan function, I started to explore the possible functional 
interactions of hyaluronan with alternative receptors, such as RHAMM, and 
hyaluronan binding proteins such as the protoglycan versican. 
On the whole the presented data demonstrated an unsuspected critical 
role of hyaluronan in the visceral skeleton morphogenesis and in particular 
in NCCs migration and differentiation. Moreover I showed for the first time 
the gene expression pattern of Xversican and XRHAMM in Xenopus laevis 
opening new working hypothesis that will be further investigated in the 
near future. 
